US FDA Approves First Telehealth Option To Remotely Program Cochlear Implants
Executive Summary
FDA approved a PMA supplement to remotely program sessions for Cochlear Americas' Nucleus Cochlear Implant System, heralding the feature as the first programming telehealth option for the hearing implants.
You may also be interested in...
DEVICE DEBUTS: Product And New Indication Launches From Medtronic, Strkyer, Siemens, And More
This month's edition of Device Debuts includes new product launches from Medtronic, Cochlear, Qualcomm, Titan Spine, Stryker, Philips, Nuance, Nevro, Siemens, Vortex BioSciences, ResMed, Respircardia, and others.
New Hybrid Hearing Device Expands Treatment Options For People With Ski-Slope Hearing Loss
Cochlear Americas launched the Cochlear Nucleus Hybrid Implant System in the US market in May 2014, a first-of-its kind technology that integrates the functions of a hearing aid and cochlear implant in a single device.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.